Efficacy of Onalespib, a Long-Acting Second-Generation HSP90 Inhibitor, as a Single Agent and in Combination With Temozolomide Against Malignant Gliomas

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-16-3151
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Pharmacokinetic Investigation of Increased Efficacy Against Malignant Gliomas of Carboplatin Combined With Hyperbaric Oxygenation

Neurologia Medico-Chirurgica
SurgeryNeurology
2009English

Malignant Gliomas as Second Neoplasms in Pediatric Cancer Survivors: Neuropathological Study

BioMed Research International
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2018English

Venetoclax as a Single Agent and in Combination With PI3K-MTOR1/2 Kinase Inhibitors Against Ibrutinib Sensitive and Resistant Mantle Cell Lymphoma

British Journal of Haematology
Hematology
2018English

In Vitro and in Vivo Efficacy of Afatinib as a Single Agent or in Combination With Gemcitabine for The treatment of Nasopharyngeal Carcinoma

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2016English

The HSP90 Inhibitor Onalespib Exerts Synergistic Anti-Cancer Effects When Combined With Radiotherapy: An in Vitro and in Vivo Approach

Scientific Reports
Multidisciplinary
2020English

Efficacy of Azithromycin as a Causal Prophylactic Agent Against Murine Malaria.

Antimicrobial Agents and Chemotherapy
Infectious DiseasesPharmacology
1994English

Second Generation mTOR Inhibitors as a Double-Edged Sword in Malignant Glioma Treatment

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2019English

Effects of a Specific and Long-Acting Renin Inhibitor in the Marmoset

Hypertension
Internal Medicine
1985English

The Strategy for Enhancing Temozolomide Against Malignant Glioma

Frontiers in Oncology
Cancer ResearchOncology
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy